REPORTS

Let’s Pullulate and Expand Your Business

Global Postmenopausal Vaginal Atrophy Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 09, 2020  |  164 PAGES  |  REPORT CODE: CMM332992
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Postmenopausal vaginal atrophy (PVA) refers to reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased elasticity of vaginal tissues. Various other factors that lead to decrease in estrogen levels include perimenopause during breast feeding, surgical menopause, pelvic radiation therapy, and chemotherapy.

The Postmenopausal Vaginal Atrophy Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period. The research provides insights for the global Postmenopausal Vaginal Atrophy Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Postmenopausal Vaginal Atrophy Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Postmenopausal Vaginal Atrophy Drugs Market Segmentations:

By Players:

  • Actavis plc

  • Novo Nordisk A/S

  • Shionogi & Company

  • Allergan plc

By Types:

  • Premarin

  • Vagifem

  • Estrace

  • Estring

  • Femring

By End-User:

  • Vaginal Gels

  • Creams

  • Tablets

  • Rings

  • Patches

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Postmenopausal Vaginal Atrophy Drugs Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Premarin from 2014 to 2026

    • 1.3.2 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Vagifem from 2014 to 2026

    • 1.3.3 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estrace from 2014 to 2026

    • 1.3.4 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estring from 2014 to 2026

    • 1.3.5 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Femring from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Vaginal Gels from 2014 to 2026

    • 1.4.2 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Creams from 2014 to 2026

    • 1.4.3 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Tablets from 2014 to 2026

    • 1.4.4 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Rings from 2014 to 2026

    • 1.4.5 Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Patches from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Postmenopausal Vaginal Atrophy Drugs Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Postmenopausal Vaginal Atrophy Drugs by Major Types

    • 3.4.1 Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Premarin

    • 3.4.2 Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Vagifem

    • 3.4.3 Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estrace

    • 3.4.4 Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estring

    • 3.4.5 Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Femring

4 Segmentation of Postmenopausal Vaginal Atrophy Drugs Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Postmenopausal Vaginal Atrophy Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Drugs in Vaginal Gels

    • 4.4.2 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Drugs in Creams

    • 4.4.3 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Drugs in Tablets

    • 4.4.4 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Drugs in Rings

    • 4.4.5 Market Size and Growth Rate of Postmenopausal Vaginal Atrophy Drugs in Patches

5 Market Analysis by Major Regions

  • 5.1 Global Postmenopausal Vaginal Atrophy Drugs Production Analysis by Major Regions

  • 5.2 Global Postmenopausal Vaginal Atrophy Drugs Consumption Analysis by Major Regions

  • 5.3 Global Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis

6 Product Commodity of Postmenopausal Vaginal Atrophy Drugs Market in Major Countries

  • 6.1 Top 5 Export Countries in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Postmenopausal Vaginal Atrophy Drugs Landscape Analysis

  • 7.1 North America Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Types

  • 7.2 North America Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major End-Users

  • 7.3 North America Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Countries

    • 7.3.1 United States Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 7.3.2 Canada Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 7.3.3 Mexico Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

8 Europe Postmenopausal Vaginal Atrophy Drugs Landscape Analysis

  • 8.1 Europe Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Types

  • 8.2 Europe Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major End-Users

  • 8.3 Europe Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Countries

    • 8.3.1 Germany Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.2 UK Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.3 France Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.4 Italy Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.6 Spain Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.7 Belgium Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.8 Poland Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.9 Russia Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 8.3.10 Turkey Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

9 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Landscape Analysis

  • 9.1 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Types

  • 9.2 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Countries

    • 9.3.1 China Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 9.3.2 Japan Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 9.3.4 India Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 9.3.6 South Korea Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

10 Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 10.3.2 Brazil Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 10.3.3 Nigeria Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

    • 10.3.4 South Africa Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate 

    • 10.3.5 Argentina Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Actavis plc

    • 11.1.1 Actavis plc Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Novo Nordisk A/S

    • 11.2.1 Novo Nordisk A/S Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Shionogi & Company

    • 11.3.1 Shionogi & Company Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Allergan plc

    • 11.4.1 Allergan plc Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 79 Figures and 170 Tables)

  • Figure Product Picture

  • Figure Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Premarin from 2014 to 2026

  • Figure Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Vagifem from 2014 to 2026

  • Figure Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estrace from 2014 to 2026

  • Figure Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Estring from 2014 to 2026

  • Figure Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Femring from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Vaginal Gels from 2014 to 2026

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Creams from 2014 to 2026

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Tablets from 2014 to 2026

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Rings from 2014 to 2026

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size and Growth Rate of Patches from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Postmenopausal Vaginal Atrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Postmenopausal Vaginal Atrophy Drugs Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Postmenopausal Vaginal Atrophy Drugs

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Postmenopausal Vaginal Atrophy Drugs by Different Types from 2014 to 2026

  • Table Consumption Share of Postmenopausal Vaginal Atrophy Drugs by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Premarin

  • Figure Market Size and Growth Rate of Vagifem

  • Figure Market Size and Growth Rate of Estrace

  • Figure Market Size and Growth Rate of Estring

  • Figure Market Size and Growth Rate of Femring

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Postmenopausal Vaginal Atrophy Drugs by Different End-Users from 2014 to 2026

  • Table Consumption Share of Postmenopausal Vaginal Atrophy Drugs by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Vaginal Gels

  • Figure Market Size and Growth Rate of Creams

  • Figure Market Size and Growth Rate of Tablets

  • Figure Market Size and Growth Rate of Rings

  • Figure Market Size and Growth Rate of Patches

  • Table Global Postmenopausal Vaginal Atrophy Drugs Production by Major Regions

  • Table Global Postmenopausal Vaginal Atrophy Drugs Production Share by Major Regions

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Production Share by Major Regions in 2014

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Production Share by Major Regions in 2018

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Production Share by Major Regions in 2026

  • Table Global Postmenopausal Vaginal Atrophy Drugs Consumption by Major Regions

  • Table Global Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Regions

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Regions in 2014

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Regions in 2018

  • Figure Global Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Regions in 2026

  • Table North America Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis

  • Table Europe Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Postmenopausal Vaginal Atrophy Drugs market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Postmenopausal Vaginal Atrophy Drugs Consumption by Types from 2014 to 2026

  • Table North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types from 2014 to 2026

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2014

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2018

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2026

  • Table North America Postmenopausal Vaginal Atrophy Drugs Consumption by End-Users from 2014 to 2026

  • Table North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2014

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2018

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2026

  • Table North America Postmenopausal Vaginal Atrophy Drugs Consumption by Major Countries from 2014 to 2026

  • Table North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2014

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2018

  • Figure North America Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2026

  • Figure United States Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption by Types from 2014 to 2026

  • Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types from 2014 to 2026

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2014

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2018

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2026

  • Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption by End-Users from 2014 to 2026

  • Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2014

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2018

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2026

  • Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption by Major Countries from 2014 to 2026

  • Table Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2014

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2018

  • Figure Europe Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2026

  • Figure Germany Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure France Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption by Types from 2014 to 2026

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2014

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2018

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2026

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2014

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2018

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2026

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2026

  • Figure China Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandPostmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure India Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Consumption Share by Major Countries in 2026

  • Figure GCC Countries Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Postmenopausal Vaginal Atrophy Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Actavis plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis plc

  • Figure Sales and Growth Rate Analysis of Actavis plc

  • Figure Revenue and Market Share Analysis of Actavis plc

  • Table Product and Service Introduction of Actavis plc

  • Table Company Profile and Development Status of Novo Nordisk A/S

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk A/S

  • Figure Sales and Growth Rate Analysis of Novo Nordisk A/S

  • Figure Revenue and Market Share Analysis of Novo Nordisk A/S

  • Table Product and Service Introduction of Novo Nordisk A/S

  • Table Company Profile and Development Status of Shionogi & Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi & Company

  • Figure Sales and Growth Rate Analysis of Shionogi & Company

  • Figure Revenue and Market Share Analysis of Shionogi & Company

  • Table Product and Service Introduction of Shionogi & Company

  • Table Company Profile and Development Status of Allergan plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan plc

  • Figure Sales and Growth Rate Analysis of Allergan plc

  • Figure Revenue and Market Share Analysis of Allergan plc

  • Table Product and Service Introduction of Allergan plc


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top